Novel genetic and epigenetic alterations in ... - Ous-research.no
Novel genetic and epigenetic alterations in ... - Ous-research.no Novel genetic and epigenetic alterations in ... - Ous-research.no
DiscussionFigure 13. Mutation detection using fragment analysis. The left panel is a sample which is wild-type for allfour genes as the electropherograms are identical to the normal control samples. To the right we see a samplewith insertion or deletion in all genes. X-axis – fluorescent intensity, Y-axis – fragment size in base pairs.To date, mutation analyses of close to 200 genes with microsatellites within their codingregion have been published in CRC[90] and 41 of the most prominent genes are included inpaper IV. With a bioinformatic genome wide approach we have identified that more than1000 protein coding genes contain 8 or more mononucleotide repeats in their codingsequence[90]. This implies that genes analyzed so far only represent the tip of the icebergand are not necessarily the ones with most impact on biological or clinical behavior.Multiplex-dependent probe amplificationAs DHPLC fail to detect large genomic rearrangements, another method was included toexamine this. MLPA was first described in 2002 as a novel method to detect copy numberchanges by PCR amplification of several ligated probes[158]. Each MLPA probe consists oftwo oligonucleotides which can be ligated to each other when hybridized adjacent to eachother on a template. All ligated probes have identical 5’ and 3’ sequences so that they can beamplified with universal PCR primers in a multiplex fashion. Only ligated oligonucleotidescan serve as template in a subsequent PCR, eliminating the need for cleaning up unboundprobes[159]. Ligated probes are co-amplified and quantified, and a decrease or increase inthe amount of the amplified probe indicates loss or gain of the exon, respectively.Several controls are included in a MLPA assay. Probes located at different genomic locationsthan the gene of interest are important in order to detect whole gene losses. Control probesscattered around the genome, preferably in regions with known copy number variation can52
Discussionserve as positive controls. Also, in the case of NF1, the exon probes were divided in twoseparate probe mixes (exon 1, 3, 5 etc. is in one probe mix and exon 2, 4, 6 etc. is in theother). In order to analyze the whole gene, the use of both probe sets will make thequantification of each exon independent from its adjacent exon. In that way there are twoexperiments that will confirm a whole gene- or a multi exon loss/gain, hence, the two probesets function as internal controls.Any factors that may interfere in probe binding will lower MLPA success. Point mutationsor indels at, or close to, the ligation site significantly causes reduced probe-sequence affinity.This may cause reduced levels of ligated and amplified product, and the probe to be scoredas deleted[159]. In our case this problem was surpassed as we performed mutation analysesin parallel, ensuring that all probes scored as deleted did not contain such aberrations in theproximity to the primers. Striving to have as equal hybridization and amplification efficiencyas possible is important as a more effective amplification of one probe may cause it to bemistakenly scored as a gain. Size is also an issue with MLPA as the fragments are separatedby this. Theoretically, as smaller fragments are amplified more efficiently than larger, it mightseem like a bad choice to use in a multiplex setup. However, if this was a general problemone would assume that the longest probes would be reported as lost in the majority of thecases. In the analysis of NF1, we did not see this effect as longer fragments had similarquantities as the smaller ones. As with all quantitative PCR assays, it is important to measurethe product while it is in the linear phase, in which the amount of the products areproportional to the copy number of the sequences. Optimal probe design, PCR-setup as wellas control regions are all taken care of when using a commercially available kit.The advantage of MLPA compared to methods such as fluorescent in situ hybridization orarray-CGH is the fact that it is far less expensive, less labor intensive, and therefore quicker.Overall, MLPA has proved to be a sensitive, time- and cost-efficient method to detect copynumber changes for a wide variety of genes[160-162].53
- Page 1 and 2: Novel genetic and epigenetic altera
- Page 3 and 4: TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6: ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8: Prefacetechnology[3]. This new tech
- Page 10 and 11: SummaryThe subgroup of carcinomas w
- Page 12 and 13: Introduction“Epigenetic inheritan
- Page 14 and 15: Introductionamino acid change it is
- Page 16 and 17: Introductionmethylation during embr
- Page 18 and 19: IntroductionDNA is most of the time
- Page 20 and 21: IntroductionFigure 5. DNA methylati
- Page 22 and 23: IntroductionFigure 6. Incidence rat
- Page 24 and 25: IntroductionFigure 8. Tumor staging
- Page 26 and 27: Introductioninasmuch as 80% of colo
- Page 28 and 29: IntroductionInstabilities involved
- Page 30 and 31: Introductionthere seems to be a fid
- Page 32 and 33: Introductionsevere alterations are
- Page 34 and 35: Introductionpopulation-wide screeni
- Page 36 and 37: IntroductionFigure 12. Present and
- Page 38 and 39: RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41: Results in Briefinstability, and se
- Page 42 and 43: Results in BriefUnivariate survival
- Page 44 and 45: Discussionseveral factors, and full
- Page 46 and 47: Discussionlow threshold, we increas
- Page 48 and 49: DiscussionIt may seem like unnecess
- Page 50 and 51: Discussionthan 96% DHPLC do not sta
- Page 54 and 55: DiscussionClinical impact of molecu
- Page 56 and 57: Discussionmarkers with a very high
- Page 58 and 59: Discussionchromosomes in metaphase[
- Page 60 and 61: DiscussionThese examples underline
- Page 62 and 63: Discussiongenes. One is based on mu
- Page 64 and 65: CONCLUSIONSWe have identified novel
- Page 66 and 67: Future PerspectivesMolecular risk a
- Page 68 and 69: REFERENCES1. Breasted J (1930) The
- Page 70 and 71: References29. Deng G, Chen A, Pong
- Page 72 and 73: References57. Al-Sukhni W, Aronson
- Page 74 and 75: References84. Kunkel TA (1993) Nucl
- Page 76 and 77: ReferencesLeggett B, Levine J, Kim
- Page 78 and 79: References133. Lind GE, Thorstensen
- Page 80 and 81: References156. Meling GI, Lothe RA,
- Page 82 and 83: ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85: References196. Honda S, Haruta M, S
- Page 86 and 87: ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90: GASTROENTEROLOGY 2007;132:1631-1639
- Page 91: Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95: Journal of Translational Medicine 2
- Page 96 and 97: Journal of Translational Medicine 2
- Page 98 and 99: Journal of Translational Medicine 2
- Page 100 and 101: Journal of Translational Medicine 2
Discussionserve as positive controls. Also, <strong>in</strong> the case of NF1, the exon probes were divided <strong>in</strong> twoseparate probe mixes (exon 1, 3, 5 etc. is <strong>in</strong> one probe mix <strong>and</strong> exon 2, 4, 6 etc. is <strong>in</strong> theother). In order to analyze the whole gene, the use of both probe sets will make thequantification of each exon <strong>in</strong>dependent from its adjacent exon. In that way there are twoexperiments that will confirm a whole gene- or a multi exon loss/ga<strong>in</strong>, hence, the two probesets function as <strong>in</strong>ternal controls.Any factors that may <strong>in</strong>terfere <strong>in</strong> probe b<strong>in</strong>d<strong>in</strong>g will lower MLPA success. Po<strong>in</strong>t mutationsor <strong>in</strong>dels at, or close to, the ligation site significantly causes reduced probe-sequence aff<strong>in</strong>ity.This may cause reduced levels of ligated <strong>and</strong> amplified product, <strong>and</strong> the probe to be scoredas deleted[159]. In our case this problem was surpassed as we performed mutation analyses<strong>in</strong> parallel, ensur<strong>in</strong>g that all probes scored as deleted did <strong>no</strong>t conta<strong>in</strong> such aberrations <strong>in</strong> theproximity to the primers. Striv<strong>in</strong>g to have as equal hybridization <strong>and</strong> amplification efficiencyas possible is important as a more effective amplification of one probe may cause it to bemistakenly scored as a ga<strong>in</strong>. Size is also an issue with MLPA as the fragments are separatedby this. Theoretically, as smaller fragments are amplified more efficiently than larger, it mightseem like a bad choice to use <strong>in</strong> a multiplex setup. However, if this was a general problemone would assume that the longest probes would be reported as lost <strong>in</strong> the majority of thecases. In the analysis of NF1, we did <strong>no</strong>t see this effect as longer fragments had similarquantities as the smaller ones. As with all quantitative PCR assays, it is important to measurethe product while it is <strong>in</strong> the l<strong>in</strong>ear phase, <strong>in</strong> which the amount of the products areproportional to the copy number of the sequences. Optimal probe design, PCR-setup as wellas control regions are all taken care of when us<strong>in</strong>g a commercially available kit.The advantage of MLPA compared to methods such as fluorescent <strong>in</strong> situ hybridization orarray-CGH is the fact that it is far less expensive, less labor <strong>in</strong>tensive, <strong>and</strong> therefore quicker.Overall, MLPA has proved to be a sensitive, time- <strong>and</strong> cost-efficient method to detect copynumber changes for a wide variety of genes[160-162].53